A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
Launched by PHARMACIA AND UPJOHN · Aug 30, 2001
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
In this open-label pilot study, patients are randomized to 1of the following 4 arms for 24 weeks:
Arm 1 (40 patients): DLV plus ZDV plus IDV. Arm 2 (40 patients): DLV plus IDV plus 3TC\*. Arm 3 (40 patients): DLV plus ZDV plus IDV plus 3TC. Arm 4 (40 patients): ZDV plus IDV plus 3TC.
* Dose determined by body weight. Patients may opt to continue on study for 24 additional weeks at the discretion of the investigator.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- Prior Medication:
- Allowed:
- • Less than 1 month prior treatment with zidovudine.
- • Exclusion Criteria
- Prior Medication:
- Excluded:
- • Prior indinavir.
- • Prior lamivudine.
- • Prior protease inhibitors.
- • Prior non-nucleoside reverse transcriptase inhibitors.
- • 1 month or more prior zidovudine.
- • 1. HIV-1 positive.
- • CD4 coun tis above 50.
- • HIV-1 RNA levels greater than 20,000.
About Pharmacia And Upjohn
Pharmacia and Upjohn, a global biopharmaceutical company, specializes in the research, development, and commercialization of innovative therapies that address unmet medical needs across multiple therapeutic areas. With a strong commitment to advancing healthcare, the company leverages cutting-edge science and technology to improve patient outcomes. Pharmacia and Upjohn is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards, ensuring the safety and efficacy of its products while fostering collaboration with healthcare professionals and regulatory authorities worldwide. Through its comprehensive portfolio, the company aims to enhance the quality of life for patients and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peapack, New Jersey, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials